How Big is the Peptide Therapeutics Market | Manufacturers & Commercial 2025

What is the size of Peptide Therapeutics Market?

Peptide Therapeutics Market is growing due to several growth factors include the rising prevalence of chronic diseases, growing focus on targeted therapies, advancements in peptide drug delivery technologies, and increasing investment in biopharmaceutical R&D.

Key Growth Drivers of the Peptide Therapeutics Market

• Increasing approval and adoption of peptide-based drugs in oncology, metabolic, and infectious diseases
• Technological innovations improving stability and bioavailability of peptides
• Rising demand for personalized and precision medicine
• Expansion of contract manufacturing organizations (CMOs) specializing in peptide therapeutics
• Favourable regulatory environment supporting faster drug approvals

Peptide Therapeutics Market Trends

Peptide Therapeutics Market is experiencing major growth with notable trends, for instance a surge in development of multifunctional peptides combining therapeutic and diagnostic features. Other trends novel delivery systems like oral, transdermal, and inhalable peptides are gaining traction. Aside from these, biosynthetic and recombinant peptide technologies are being increasingly adopted. The partnerships between biotech firms and research institutions are accelerating the pipeline development and clinical trials.

Emerging Developments in the Peptide Therapeutics Market

Peptide Therapeutics Market is developing throughout the years with the use of artificial intelligence and machine learning for peptide drug design and optimization is on the rise. Aside from these, there is development of peptide-drug conjugates for targeted cancer therapy is expanding. Innovations are occurring in the peptide vaccine platforms are advancing immunotherapy. The focus is emphasizing on peptide-based treatments for rare and orphan diseases is observed.

List of Leading Companies in the Peptide Therapeutics Market

Below is a comprehensive list of the leading market players driving growth in this sector:

1. Ipsen Pharma

This company is a global biopharmaceutical company focused on peptide-based therapies and offers treatments in oncology, endocrinology, and rare diseases.

2. Eli Lilly and Company

This company develops innovative peptide drugs across multiple therapeutic areas and strong pipeline in diabetes and oncology peptides.

3. Novo Nordisk A/S

This company is a leader in peptide-based treatments for diabetes and obesity and offers advanced GLP-1 receptor agonists and analogues.

4. Helsinn Group

This company specializes in oncology peptide therapeutics and supportive care products and focuses on patient-centric innovation and global reach.

5. Amgen Inc.

This company is a biotech leader developing peptide therapeutics for inflammation and cancer and has strong capabilities in biologics and peptide conjugates.

6. Ipsen Pharma

This company offers innovative peptide-based therapies with a global footprint and focused on endocrinology and oncology indications.

7. PeptiDream Inc.

This company develops proprietary peptide drug discovery platforms and collaborates with pharma companies for therapeutic peptides.

8. MedImmune

This company is biologics arm of AstraZeneca developing peptide-based therapies and focused on oncology, respiratory, and cardiovascular diseases.

How Big is the Peptide Therapeutics Market : FAQs